MolNFT v1 · #81158 · protein
MAP kinase LMAMPK10 from leishmania major in complex with SB203580
3UIB · Mitogen-activated protein kinase: “MAP kinase LMAMPK10 from leishmania major in complex with SB203580”. X-ray diffraction, 1 ligand (SB2), 7 pockets (best druggability 0.63). MolNFT v1 #81158 on GenesisL1: 3D structure, binding…
- PDB
- 3UIB
- Type
- protein
- Length
- 309 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Mitogen-activated protein kinase
- EC
- 2.7.11.1
- UniProt
- Q4QHJ8
- Ligands
- SB2
- Pockets
- 7 · best druggability 0.63
Structure
x-ray diffraction · 1 distinct chain · 43% helix, 9% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Mitogen-activated protein kinase (EC 2.7.11.1) | protein | 309 | 43% helix, 9% strand | Q4QHJ8 |
Ligands and binding sites
- SB2 · 4-[5-(4-fluoro-phenyl)-2-(4-methanesulfinyl-phenyl)-3H-imidazol-4-yl]-pyridine · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 327 | 0.63 | 0.79 | 34 | SB2 |
| 2 | 103 | 0.52 | 0.82 | 16 | empty |
| 3 | 165 | 0.51 | 0.78 | 24 | empty |
| 4 | 78 | 0.38 | 0.77 | 22 | empty |
| 5 | 74 | 0.31 | 0.74 | 20 | empty |
Compared structures
- 3UIB · Map kinase LMAMPK10 from leishmania major in complex with SB203580 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q4QHJ8
- Elsewhere: RCSB PDB 3UIB · PDBe 3UIB · UniProt Q4QHJ8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.